Q9Y613 (FHOD1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 106.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: FH1/FH2 domain-containing protein 1 Alternative name(s): Formin homolog overexpressed in spleen 1 Short name=FHOS Formin homology 2 domain-containing protein 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1164 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Required for the assembly of F-actin structures, such as stress fibers. Depends on the Rho-ROCK cascade for its activity. Contributes to the coordination of microtubules with actin fibers and plays a role in cell elongation. Acts synergistically with ROCK1 to promote SRC-dependent non-apoptotic plasma membrane blebbing. Ref.2 Ref.8 Ref.9 |
| Subunit structure | Self-associates via the FH2 domain. Binds to F-actin via its N-terminus. Binds to the cytoplasmic domain of CD21 via its C-terminus. Interacts with ROCK1 in a Src-dependent manner. Ref.2 Ref.3 Ref.9 |
| Subcellular location | Cytoplasm. Cytoplasm › cytoskeleton. Cell projection › bleb. Note: Predominantly cytoplasmic. Ref.8 Ref.9 |
| Tissue specificity | Ubiquitous. Highly expressed in spleen. |
| Domain | Regulated by intramolecular binding to a C-terminal auto-inhibitory domain. Effector binding abolishes this interaction and activates the protein. |
| Post-translational modification | Phosphorylated by ROCK1. Ref.7 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 |
| Sequence similarities | Belongs to the formin homology family. Contains 1 FH1 (formin homology 1) domain. Contains 1 FH2 (formin homology 2) domain. Contains 1 GBD/FH3 (Rho GTPase-binding/formin homology 3) domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell projection Cytoplasm Cytoskeleton |
| Domain | Coiled coil |
| Ligand | Actin-binding |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological process | actin cytoskeleton organization Inferred from electronic annotation. Source: InterPro positive regulation of stress fiber assemblyInferred from direct assay. Source: BHF-UCL positive regulation of transcription from RNA polymerase II promoterInferred from direct assay. Source: BHF-UCL |
| Cellular component | bleb Inferred from electronic annotation. Source: UniProtKB-SubCell cytoplasmInferred from direct assay. Source: HPA cytoskeletonInferred from electronic annotation. Source: UniProtKB-SubCell nucleusInferred from direct assay. Source: BHF-UCL |
| Molecular function | actin binding Inferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 2 – 1164 | 1163 | FH1/FH2 domain-containing protein 1 | PRO_0000194905 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 53 – 458 | 406 | GBD/FH3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 487 – 615 | 129 | FH1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 616 – 1013 | 398 | FH2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 612 – 807 | 196 | Interaction with ROCK1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Coiled coil | 884 – 921 | 38 | Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 583 – 593 | 11 | Poly-Pro | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 597 – 605 | 9 | Poly-Pro | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 996 – 1001 | 6 | Poly-Gln | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 367 | 1 | Phosphoserine Ref.7 Ref.12 Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 486 | 1 | Phosphoserine Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 495 | 1 | Phosphothreonine Ref.10 Ref.12 Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 498 | 1 | Phosphoserine Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 523 | 1 | Phosphoserine Ref.10 Ref.12 Ref.13 Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 573 | 1 | Phosphoserine Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 690 | 1 | Phosphothreonine Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 249 | 1 | S → T in AAD39906. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 249 | 1 | S → T in AAO38757. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 264 | 1 | E → D in AAO38757. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 277 | 1 | T → M in BAD06250. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 307 – 308 | 2 | EA → DT in AAD39906. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 307 – 308 | 2 | EA → DT in AAO38757. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 359 | 1 | E → D in AAO38757. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 387 | 1 | S → T in AAO38757. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 533 | 1 | P → L in BAD92821. Ref.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 633 – 634 | 2 | EL → DV in AAD39906. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 689 | 1 | R → Q in AAO38757. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 700 | 1 | S → T in AAD39906. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 745 | 1 | E → G in AAO38757. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 751 | 1 | E → G in AAD39906. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 849 | 1 | E → D in AAD39906. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1061 | 1 | P → L in AAD39906. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1061 | 1 | P → L in AAO38757. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 16 – 22 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 36 – 39 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 42 – 45 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 55 – 61 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 68 – 76 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 88 – 93 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 99 – 103 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 109 – 114 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 116 – 129 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 134 – 147 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 152 – 158 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 163 – 167 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 174 – 183 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 187 – 189 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 201 – 209 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 210 – 212 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 216 – 232 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 234 – 236 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 237 – 250 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 257 – 263 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 271 – 287 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 291 – 303 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 307 – 313 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 321 – 337 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification and characterization of a protein containing formin homology (FH1/FH2) domains." Westendorf J.J., Mernaugh R., Hiebert S.W. Gene 232:173-182(1999) [PubMed: 10352228] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Fhos, a mammalian formin, directly binds to F-actin via a region N-terminal to the FH1 domain and forms a homotypic complex via the FH2 domain to promote actin fiber formation." Takeya R., Sumimoto H. J. Cell Sci. 116:4567-4575(2003) [PubMed: 14576350] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT. |
| [3] | "EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21." Gill M.B., Roecklein-Canfield J., Sage D.R., Zambela-Soediono M., Longtine N., Uknis M., Fingeroth J.D. J. Cell Sci. 117:2709-2720(2004) [PubMed: 15138285] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Prostate. |
| [5] | "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides." Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., Vandekerckhove J. Nat. Biotechnol. 21:566-569(2003) [PubMed: 12665801] [Abstract] Cited for: PROTEIN SEQUENCE OF 2-19. Tissue: Platelet. |
| [6] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 148-1164. Tissue: Spleen. |
| [7] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [8] | "FHOD1 coordinates actin filament and microtubule alignment to mediate cell elongation." Gasteier J.E., Schroeder S., Muranyi W., Madrid R., Benichou S., Fackler O.T. Exp. Cell Res. 306:192-202(2005) [PubMed: 15878344] [Abstract] Cited for: FUNCTION, AUTOINHIBITION, SUBCELLULAR LOCATION. |
| [9] | "The diaphanous-related formin FHOD1 associates with ROCK1 and promotes Src-dependent plasma membrane blebbing." Hannemann S., Madrid R., Stastna J., Kitzing T., Gasteier J., Schoenichen A., Bouchet J., Jimenez A., Geyer M., Grosse R., Benichou S., Fackler O.T. J. Biol. Chem. 283:27891-27903(2008) [PubMed: 18694941] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH ROCK1, PHOSPHORYLATION. |
| [10] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-495; SER-498 AND SER-523, MASS SPECTROMETRY. Tissue: Platelet. |
| [11] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; SER-486; THR-495; SER-498; SER-523 AND SER-573, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; THR-495; SER-498; SER-523 AND THR-690, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498 AND SER-523, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [15] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF113615 mRNA. Translation: AAD39906.1. AB041046 mRNA. Translation: BAD06250.1. AY192154 mRNA. Translation: AAO38757.1. BC033084 mRNA. Translation: AAH33084.1. AB209584 mRNA. Translation: BAD92821.1. | ||||||||||||
| IPI | IPI00001730. | ||||||||||||
| RefSeq | NP_037373.2. NM_013241.2. | ||||||||||||
| UniGene | Hs.95231. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q9Y613. | ||||||||||||
| SMR | Q9Y613. Positions 14-339. | ||||||||||||
| DisProt | DP00448. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-31134N. | ||||||||||||
| IntAct | Q9Y613. 11 interactions. | ||||||||||||
| MINT | MINT-1033686. | ||||||||||||
| STRING | Q9Y613. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q9Y613. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 62512187. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | Q9Y613. | ||||||||||||
| PRIDE | Q9Y613. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000258201; ENSP00000258201; ENSG00000135723. | ||||||||||||
| GeneID | 29109. | ||||||||||||
| KEGG | hsa:29109. | ||||||||||||
| UCSC | uc002esl.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 29109. | ||||||||||||
| GeneCards | GC16M067263. | ||||||||||||
| H-InvDB | HIX0013142. | ||||||||||||
| HGNC | HGNC:17905. FHOD1. | ||||||||||||
| HPA | HPA024468. | ||||||||||||
| MIM | 606881. gene. | ||||||||||||
| neXtProt | NX_Q9Y613. | ||||||||||||
| PharmGKB | PA28143. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG10799. | ||||||||||||
| GeneTree | ENSGT00560000076948. | ||||||||||||
| HOGENOM | HBG446794. | ||||||||||||
| HOVERGEN | HBG051615. | ||||||||||||
| InParanoid | Q9Y613. | ||||||||||||
| OMA | QLMLFVD. | ||||||||||||
| OrthoDB | EOG4Q58NW. | ||||||||||||
| PhylomeDB | Q9Y613. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q9Y613. | ||||||||||||
| Bgee | Q9Y613. | ||||||||||||
| CleanEx | HS_FHOD1. | ||||||||||||
| Genevestigator | Q9Y613. | ||||||||||||
| GermOnline | ENSG00000135723. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR003104. Actin-bd_FH2/DRF_autoreg. IPR011989. ARM-like. IPR016024. ARM-type_fold. IPR015425. FH2_actin-bd. IPR014768. GTPase-bd/formin_homology_3. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:1.25.10.10. ARM-like. 1 hit. | ||||||||||||
| Pfam | PF02181. FH2. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00498. FH2. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF48371. ARM-type_fold. 1 hit. SSF101447. FH2_actin_bd. 1 hit. | ||||||||||||
| PROSITE | PS51444. FH2. 1 hit. PS51232. GBD_FH3. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| NextBio | 52175. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | FHOD1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y613 Secondary accession number(s): Q59F76 Q8N521 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with